MHMing-I Hsieh

Ming-I Hsieh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ming-I Hsieh has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Chang-Wen Chen

    Section of Critical Care Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng-Kung University, Tainan, Taiwan

    1 shared publication
  • Chi-Jung Wu

    Division of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University

    1 shared publication
  • Chih-Cheng Hsieh

    Division of Critical Care Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    1 shared publication
  • Cong-Tat Cia

    Department of Internal Medicine, College of Medicine, National Cheng Kung University, National Cheng Kung University Hospital

    1 shared publication
  • Hsuan-Chen Wang

    National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan 70403, Taiwan

    1 shared publication
  • Jen-Chieh Lee

    Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016–2019

    by Chi-Jung Wu, Cong-Tat Cia, Hsuan-Chen Wang, Chang-Wen Chen, Wei-Chieh Lin, Jen-Chieh Lee, Po-Sheng Chen, Chih-Cheng Hsieh, Wei-Ting Li, Po-Lan Su, et al.

    This study delineated the characteristics of 24 (11.2%) culture-positive, influenza-associated pulmonary aspergillosis (IAPA) patients out of 215 patients with severe influenza during 2016–2019 in a medical center in southern Taiwan. Twenty (83.3%) patients did not have EORTC/MSG-defined host factors. The mean time from influenza diagnosis to Aspergillus growth was 4.4 days, and 20 (83.3%) developed IAPA within seven days after influenza diagnosis. All patients were treated in intensive care units and all but one (95.8%) received mechanical ventilation. Aspergillus tracheobronchitis was evident in 6 (31.6%) of 19 patients undergoing bronchoscopy. Positive galactomannan testing of either serum or bronchoalveolar lavage was noted in all patients. On computed tomography imaging, IAPA was characterized by peribronchial infiltrates, multiple nodules, and cavities superimposed on ground-glass opacities. Pure Aspergillus growth without bacterial co-isolation in culture was found in 17 (70.8%) patients. A. fumigatus (15, 62.5%), A. flavus (6, 25.0%), and A. terreus (4, 16.7%) were the major causative species. Three patients had mixed Aspergillus infections due to two species, and two had mixed azole-susceptible and azole-resistant A. fumigatus infection. All patients received voriconazole with an all-cause mortality of 41.6%. Of 14 survivors, the mean duration of antifungal use was 40.5 days. In conclusion, IAPA is an early and rapidly deteriorating complication following influenza that necessitates clinical vigilance and prompt diagnostic workup.